Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 20 March 2009:
Vol. 323. no. 5921, pp. 1564 - 1565
DOI: 10.1126/science.1168451

Policy Forum

MEDICINE:
Monitoring and Regulating Offshore Stem Cell Clinics

Sorapop Kiatpongsan1,2,3 and Douglas Sipp4,5*

Unverified medical treatments based on stem cells are proliferating and need oversight.


1Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 10330.

2Vincent Center for Reproductive Biology, Vincent Obstetrics and Gynecology Service, Massachusetts General Hospital/Harvard Medical School, Boston, MA 02114, USA.

3Science, Technology and Globalization Project/Science, Technology and Public Policy Program, Belfer Center for Science and International Affairs, John F. Kennedy School of Government, Harvard University, Cambridge, MA 02138, USA.

4RIKEN Center for Developmental Biology, Kobe, 650-0047, Japan.

5Center for iPS Research and Application, Institute for Integrated Cell-Materials Sciences, Kyoto University, Kyoto, 606-8501, Japan.

*Author for correspondence. E-mail: sipp{at}cdb.riken.jp

Read the Full Text





To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)